Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. There is an urgent need to update tre...
Neisseria gonorrhoeae,
Gonorrhea/drug therapy,
Drug Resistance, Microbial,
Cefixime/administration & dosage,
Spectinomycin/administration & dosage,
Ceftriaxone/administration & dosage,
Gentamicins/administration & dosage,
Kanamycin/administration & dosage,
Tetracycline/administration & dosage,
Erythromycin/administration & dosage,
Povidone-Iodine/administration & dosage,
Silver Nitrate/administration & dosage,
Chloramphenicol/therapeutic use,
Anti-Bacterial Agents/administration & dosage,
Drug Therapy, Combination
Infections are responsible for about one fifth of the world’s annual 2.7 million neonatal deaths. In South Asia and sub-Saharan Africa about one quarter of all neonatal deaths are due to infections. Many sick infants only have non-specific signs, and thus are not recognized to have infection. Even when...
The microbial causes of pneumonia vary according to its origin and the immune constitution of the patient. Pneumonia is classified into community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP) and pneumonia in the immunocompromised. The guideline development process is guided by its scope - ...
Dans le but d’accroître le nombre d’enfants ayant accès au traitement adapté, la classification et le guide thérapeutique simplifiés de l’OMS pour la prise en charge de la pneumonie de l’enfant dans les établissements de santé de premier niveau et les services de consultation ambulatoire o...
The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces oral c...
Pneumonia/drug therapy,
Anti-Bacterial Agents/administration & dosage,
Severity of Illness Index,
Health Facilities,
Amoxicillin/administration & dosage,
Gentamicins/administration & dosage,
Chloramphenicol/administration & dosage,
Ampicillin/administration & dosage,
Ceftriaxone/administration & dosage,
Trimethoprim, Sulfamethoxazole Drug Combination/administration & dosage
Se realizó el análisis de la priorización de la guía en conjunto con el MSPS. Para el análisis se aplicaron los instrumentos sugeridos por la Guía Metodológica. La priorización se basó en el peso de las diferentes situaciones en la morbimortalidad de los niños menores de 5 años (carga de enfer...
Elaborar unas recomendaciones que faciliten la toma de decisiones por parte del profesional en el momento de indicar la cirugía de catarata y estandarizar el proceso quirúrgico disminuyendo la variabilidad de la practica clínica en todas las etapas del mismo. También pretende favorecer el entendimien...
Cataract/diagnosis,
Cataract/rehabilitation,
Cataract/drug therapy,
Cataract Extraction/rehabilitation,
Risk Factors,
Critical Pathways/organization & administration,
Angiogenesis Inhibitors/therapeutic use,
Anti-Bacterial Agents/therapeutic use,
Anti-Inflammatory Agents/therapeutic use,
Ophthalmic Solutions/therapeutic use,
Ophthalmoscopy/methods
Las infecciones del tracto urinario (ITUs) y más concretamente de las vías bajas no
complicadas (cistitis) constituyen, después de las respiratorias, el segundo grupo en
importancia de infecciones extrahospitalarias, y son una causa frecuente de consulta en
atención primaria (AP)1
.
Sus característi...
Optimizar el manejo clínico de la EMI en la población infantojuvenil, con recomendaciones orientadas a lograr la detección precoz y una rápida instauración del tratamiento que permitan reducir la elevada morbilidad y mortalidad asociadas a la enfermedad; Ofrecer a los profesionales sanitarios que de...
This guideline covers preventing, identifying and managing neutropenic sepsis in children, young people and adults receiving treatment for cancer in the community and in secondary and tertiary care. It aims to reduce the risk of infection in people with neutropenia (low number of white blood cells) who a...
